8 October 2015 - Deborah Wilkes
Archived
Perrigo plans to develop a portfolio of extended-release oral suspension products for the US OTC market using Flamel's LiquiTime technology.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.